← FDA DRUG APPROVALS

FDA ANDA · ANDA077024

CILOSTAZOL

Sponsor: HIKMA

APPLICATION
ANDA077024
TYPE
ANDA
ORIGINAL APPROVAL
2005-05-17
LATEST ACTION
2016-03-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CILOSTAZOLDiscontinued
CILOSTAZOL 100MG · TABLET · ORAL
CILOSTAZOLDiscontinued
CILOSTAZOL 50MG · TABLET · ORAL

Approval history

2016-03-25Labeling · Supplement 7 · standardAP
2016-03-25Labeling · Supplement 8 · standardAP
2008-09-09Labeling · Supplement 2AP
2008-07-09Labeling · Supplement 1AP
2005-05-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →